Neither the infiltration of CD4+ TILs nor that of CD8+ TILs showed prognostic value in EGFR and HER2 mutant NSCLC (P = 0.503, P = 0.095, respectively; Fig 3). Here, ERBB2 is linked to non-small cell lung carcinoma.